Skip to content

Acupuncture for Pain Control After Elective Caesarean Section

Acupuncture vs. Placebo Acupuncture and vs. Standard Therapy for Pain Control After Elective Caesarean Section - a Randomized Controlled Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02364167
Acronym
ACUSEC
Enrollment
180
Registered
2015-02-16
Start date
2015-01-13
Completion date
2018-06-27
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

The study entitled Acupuncture vs. placebo acupuncture and vs. standard therapy for pain control after elective caesarian section - a randomized controlled trial aims to investigate whether acupuncture with indwelling fixed needles reduces pain and analgesic requirement as compared to placebo and standard therapy in patients after after elective caesarian section (CS) in the period from January 2015 to May 2016. For that purpose 180 adult patients scheduled to elective elective CS in spinal anesthesia will be recruited according to eligibility criteria. 120 patients will be randomized either to verum or placebo acupuncture, 60 patients will be included in non-randomized standard therapy arm. The outcome measures are: postoperative analgesic requirement, pain intensity, incidence of side effects and physiological parameters.

Interventions

DRUGStandard therapy

Standard therapy includes pharmacologic treatment of postoperative pain according to the standards of our University hospital

Verum acupuncture will be performed using indwelling permanent acupuncture needles New Pyonex with 1,5 mm length, manufactured by Seirin Corp. Japan

OTHERPlacebo acupuncture

Placebo acupuncture will be performed using the placebo New Pyonex adhesive tapes, mimicking the needles, manufactured by Seirin Corp. Japan

Sponsors

University Medicine Greifswald
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Patients with an American Society of Anaesthesiologists physical status of I to III scheduled for elective caesarean section in spinal anaesthesia * Surgery time does not exceed 60 minutes * Patients without previous opioid and psychotropic medication * Patients ranged 19-45 years old * Patients who have given written informed consent

Exclusion criteria

* Recidivist alcoholics * Local skin infection at the sites of acupuncture * Age \< 19 and \> 45 years * Switching to general anaesthesia in cases where spinal anaesthesia fails * Surgery time more than 60 minutes * Intraoperative complications (bleeding, required blood transfusion more than 6 units of packed cells, cardiovascular instability, required catecholamines except for short hypotension after induction of spinal anaesthesia ) * Patients who consumed opioid medication at least 6 months before surgery * Patients who are unable to understand the consent form and fill in the study questionnaire * History of psychiatric disease

Design outcomes

Primary

MeasureTime frame
Pain intensity as measured by Numeric Rating Scale 1-104:00 P.M. on the 1st postoperative day

Secondary

MeasureTime frame
Total requirement of postoperative analgesics4:00 P.M. on the 2nd postoperative day
Incidence of complications and adverse effects4:00 P.M. on the 2nd postoperative day

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026